Through workshops, exhibitions and public lectures, Cramer is creating a connection between quantum developments and society. Her goal is to make quantum technology accessible and broad-based, which is crucial to making it more inclusive and socially relevant.
“My goal is to place quantum more into society,” Cramer says. From the Leiden Bio Science Park, this will make an essential contribution to science communication and social awareness around quantum technology, engaging diverse audiences to prevent social inequality.
Source: summarized from NRC article, Nov. 11, 2024.
As of June, the Leiden Bio Science Park team has been joined by Gerwin Zomer, who steps into the role of Account Manager Physical Living Environment. To get to know him a bit...
Researchers at the Leiden University Medical Center (LUMC) have announced promising early results from a clinical trial using lab-grown insulin-producing islet cells derived from...
VarmX has received IND approval for its Phase 3 trial of VMX‑C001, a recombinant factor X variant designed to neutralize FXa‑inhibiting anticoagulants during emergency surgery. Backed by robust Phase 1 data and boosted by a €15 million EIC investment, this step positions VMX‑C001 to meet a gap in urgent haemostasis care.